[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Metastatic Prostate Cancer Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: M9204767CF18EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Metastatic Prostate Cancer Treatment in Global, including the following market information:

Global Metastatic Prostate Cancer Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Metastatic Prostate Cancer Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metastatic Prostate Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metastatic Prostate Cancer Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Metastatic Prostate Cancer Treatment Market Segment Percentages, By Type, 2020 (%)
  • Mono
  • Combination
  • Mono/Combination
China Metastatic Prostate Cancer Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Metastatic Prostate Cancer Treatment Market Segment Percentages, By Application, 2020 (%)
  • Hospital
  • Drug Store
  • Online Pharmacy
Global Metastatic Prostate Cancer Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Metastatic Prostate Cancer Treatment Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Metastatic Prostate Cancer Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Metastatic Prostate Cancer Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • AB Science
  • BeiGene
  • eFFECTOR Therapeutics
  • Immunomedics(Gilead Sciences, Inc.)
  • Myovant Biosciences
  • SeleXel
  • Zenith Epigenetics Ltd.
  • VasGene Therapeutics, Inc.
  • Telix Pharmaceuticals
  • Arvinas Inc.
  • Amgen
  • Genentech
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 LMS-Frontline Worker Training Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global LMS-Frontline Worker Training Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LMS-FRONTLINE WORKER TRAINING OVERALL MARKET SIZE

2.1 Global LMS-Frontline Worker Training Market Size: 2021 VS 2027
2.2 Global LMS-Frontline Worker Training Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top LMS-Frontline Worker Training Players in Global Market
3.2 Top Global LMS-Frontline Worker Training Companies Ranked by Revenue
3.3 Global LMS-Frontline Worker Training Revenue by Companies
3.4 Top 3 and Top 5 LMS-Frontline Worker Training Companies in Global Market, by Revenue in 2020
3.5 Global Companies LMS-Frontline Worker Training Product Type
3.6 Tier 1, Tier 2 and Tier 3 LMS-Frontline Worker Training Players in Global Market
  3.6.1 List of Global Tier 1 LMS-Frontline Worker Training Companies
  3.6.2 List of Global Tier 2 and Tier 3 LMS-Frontline Worker Training Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global LMS-Frontline Worker Training Market Size Markets, 2021 & 2027
  4.1.2 Collaborative Learning
  4.1.3 Content Management
  4.1.4 Talent Management
  4.1.5 Performance Management
  4.1.6 Others
4.2 By Type - Global LMS-Frontline Worker Training Revenue & Forecasts
  4.2.1 By Type - Global LMS-Frontline Worker Training Revenue, 2016-2021
  4.2.2 By Type - Global LMS-Frontline Worker Training Revenue, 2022-2027
  4.2.3 By Type - Global LMS-Frontline Worker Training Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global LMS-Frontline Worker Training Market Size, 2021 & 2027
  5.1.2 Information Technology
  5.1.3 Healthcare
  5.1.4 Transport
  5.1.5 Retail
  5.1.6 Manufacturing
  5.1.7 Telecommunication
  5.1.8 Food and Beverage
  5.1.9 Others
5.2 By Application - Global LMS-Frontline Worker Training Revenue & Forecasts
  5.2.1 By Application - Global LMS-Frontline Worker Training Revenue, 2016-2021
  5.2.2 By Application - Global LMS-Frontline Worker Training Revenue, 2022-2027
  5.2.3 By Application - Global LMS-Frontline Worker Training Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global LMS-Frontline Worker Training Market Size, 2021 & 2027
6.2 By Region - Global LMS-Frontline Worker Training Revenue & Forecasts
  6.2.1 By Region - Global LMS-Frontline Worker Training Revenue, 2016-2021
  6.2.2 By Region - Global LMS-Frontline Worker Training Revenue, 2022-2027
  6.2.3 By Region - Global LMS-Frontline Worker Training Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America LMS-Frontline Worker Training Revenue, 2016-2027
  6.3.2 US LMS-Frontline Worker Training Market Size, 2016-2027
  6.3.3 Canada LMS-Frontline Worker Training Market Size, 2016-2027
  6.3.4 Mexico LMS-Frontline Worker Training Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe LMS-Frontline Worker Training Revenue, 2016-2027
  6.4.2 Germany LMS-Frontline Worker Training Market Size, 2016-2027
  6.4.3 France LMS-Frontline Worker Training Market Size, 2016-2027
  6.4.4 U.K. LMS-Frontline Worker Training Market Size, 2016-2027
  6.4.5 Italy LMS-Frontline Worker Training Market Size, 2016-2027
  6.4.6 Russia LMS-Frontline Worker Training Market Size, 2016-2027
  6.4.7 Nordic Countries LMS-Frontline Worker Training Market Size, 2016-2027
  6.4.8 Benelux LMS-Frontline Worker Training Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia LMS-Frontline Worker Training Revenue, 2016-2027
  6.5.2 China LMS-Frontline Worker Training Market Size, 2016-2027
  6.5.3 Japan LMS-Frontline Worker Training Market Size, 2016-2027
  6.5.4 South Korea LMS-Frontline Worker Training Market Size, 2016-2027
  6.5.5 Southeast Asia LMS-Frontline Worker Training Market Size, 2016-2027
  6.5.6 India LMS-Frontline Worker Training Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America LMS-Frontline Worker Training Revenue, 2016-2027
  6.6.2 Brazil LMS-Frontline Worker Training Market Size, 2016-2027
  6.6.3 Argentina LMS-Frontline Worker Training Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa LMS-Frontline Worker Training Revenue, 2016-2027
  6.7.2 Turkey LMS-Frontline Worker Training Market Size, 2016-2027
  6.7.3 Israel LMS-Frontline Worker Training Market Size, 2016-2027
  6.7.4 Saudi Arabia LMS-Frontline Worker Training Market Size, 2016-2027
  6.7.5 UAE LMS-Frontline Worker Training Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Blackboard Inc.(Providence Equity Partners LLC)
  7.1.1 Blackboard Inc.(Providence Equity Partners LLC) Corporate Summary
  7.1.2 Blackboard Inc.(Providence Equity Partners LLC) Business Overview
  7.1.3 Blackboard Inc.(Providence Equity Partners LLC) LMS-Frontline Worker Training Major Product Offerings
  7.1.4 Blackboard Inc.(Providence Equity Partners LLC) LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.1.5 Blackboard Inc.(Providence Equity Partners LLC) Key News
7.2 Oracle Corporation
  7.2.1 Oracle Corporation Corporate Summary
  7.2.2 Oracle Corporation Business Overview
  7.2.3 Oracle Corporation LMS-Frontline Worker Training Major Product Offerings
  7.2.4 Oracle Corporation LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.2.5 Oracle Corporation Key News
7.3 Kenexa (IBM)
  7.3.1 Kenexa (IBM) Corporate Summary
  7.3.2 Kenexa (IBM) Business Overview
  7.3.3 Kenexa (IBM) LMS-Frontline Worker Training Major Product Offerings
  7.3.4 Kenexa (IBM) LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.3.5 Kenexa (IBM) Key News
7.4 Adobe Captivate Prime
  7.4.1 Adobe Captivate Prime Corporate Summary
  7.4.2 Adobe Captivate Prime Business Overview
  7.4.3 Adobe Captivate Prime LMS-Frontline Worker Training Major Product Offerings
  7.4.4 Adobe Captivate Prime LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.4.5 Adobe Captivate Prime Key News
7.5 CrossKnowledge
  7.5.1 CrossKnowledge Corporate Summary
  7.5.2 CrossKnowledge Business Overview
  7.5.3 CrossKnowledge LMS-Frontline Worker Training Major Product Offerings
  7.5.4 CrossKnowledge LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.5.5 CrossKnowledge Key News
7.6 Canvas LMS
  7.6.1 Canvas LMS Corporate Summary
  7.6.2 Canvas LMS Business Overview
  7.6.3 Canvas LMS LMS-Frontline Worker Training Major Product Offerings
  7.6.4 Canvas LMS LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.6.5 Canvas LMS Key News
7.7 D2L Corporation
  7.7.1 D2L Corporation Corporate Summary
  7.7.2 D2L Corporation Business Overview
  7.7.3 D2L Corporation LMS-Frontline Worker Training Major Product Offerings
  7.4.4 D2L Corporation LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.7.5 D2L Corporation Key News
7.8 Cornerstone
  7.8.1 Cornerstone Corporate Summary
  7.8.2 Cornerstone Business Overview
  7.8.3 Cornerstone LMS-Frontline Worker Training Major Product Offerings
  7.8.4 Cornerstone LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.8.5 Cornerstone Key News
7.9 Latitude Learning
  7.9.1 Latitude Learning Corporate Summary
  7.9.2 Latitude Learning Business Overview
  7.9.3 Latitude Learning LMS-Frontline Worker Training Major Product Offerings
  7.9.4 Latitude Learning LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.9.5 Latitude Learning Key News
7.10 McGraw Hill
  7.10.1 McGraw Hill Corporate Summary
  7.10.2 McGraw Hill Business Overview
  7.10.3 McGraw Hill LMS-Frontline Worker Training Major Product Offerings
  7.10.4 McGraw Hill LMS-Frontline Worker Training Revenue in Global (2016-2021)
  7.10.5 McGraw Hill Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Metastatic Prostate Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Metastatic Prostate Cancer Treatment Market Drivers in Global Market
Table 3. Metastatic Prostate Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Metastatic Prostate Cancer Treatment in Global Market
Table 5. Top Metastatic Prostate Cancer Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Metastatic Prostate Cancer Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Metastatic Prostate Cancer Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Metastatic Prostate Cancer Treatment Product Type
Table 9. List of Global Tier 1 Metastatic Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Metastatic Prostate Cancer Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Metastatic Prostate Cancer Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Metastatic Prostate Cancer Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2022-2027
Table 30. AB Science Corporate Summary
Table 31. AB Science Metastatic Prostate Cancer Treatment Product Offerings
Table 32. AB Science Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 33. BeiGene Corporate Summary
Table 34. BeiGene Metastatic Prostate Cancer Treatment Product Offerings
Table 35. BeiGene Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 36. eFFECTOR Therapeutics Corporate Summary
Table 37. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product Offerings
Table 38. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Immunomedics(Gilead Sciences, Inc.) Corporate Summary
Table 40. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product Offerings
Table 41. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Myovant Biosciences Corporate Summary
Table 43. Myovant Biosciences Metastatic Prostate Cancer Treatment Product Offerings
Table 44. Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 45. SeleXel Corporate Summary
Table 46. SeleXel Metastatic Prostate Cancer Treatment Product Offerings
Table 47. SeleXel Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Zenith Epigenetics Ltd. Corporate Summary
Table 49. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product Offerings
Table 50. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 51. VasGene Therapeutics, Inc. Corporate Summary
Table 52. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Product Offerings
Table 53. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Telix Pharmaceuticals Corporate Summary
Table 55. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product Offerings
Table 56. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Arvinas Inc. Corporate Summary
Table 58. Arvinas Inc. Metastatic Prostate Cancer Treatment Product Offerings
Table 59. Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Amgen Corporate Summary
Table 61. Amgen Metastatic Prostate Cancer Treatment Product Offerings
Table 62. Amgen Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)
Table 63. Genentech Corporate Summary
Table 64. Genentech Metastatic Prostate Cancer Treatment Product Offerings
Table 65. Genentech Metastatic Prostate Cancer Treatment Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Metastatic Prostate Cancer Treatment Segment by Type
Figure 2. Metastatic Prostate Cancer Treatment Segment by Application
Figure 3. Global Metastatic Prostate Cancer Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Metastatic Prostate Cancer Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Metastatic Prostate Cancer Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2020
Figure 8. By Type - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 12. US Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 24. China Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Metastatic Prostate Cancer Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Metastatic Prostate Cancer Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. AB Science Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BeiGene Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Myovant Biosciences Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. SeleXel Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Arvinas Inc. Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Amgen Metastatic Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications